The Pattern of Substance Abuse in the Psychiatry Department of a Tertiary Care of Srinagar Hospital, Jammu and Kashmir, India

被引:2
作者
Maqbool, Mudasir [1 ]
Fekadu, Ginenus [2 ]
Dugassa, Dinka [2 ]
Bekele, Firomsa [3 ]
Turi, Ebisa [4 ]
Simegnew, Dawit [5 ]
机构
[1] Univ Kashmir, Dept Pharmaceut Sci, Srinagar, Jammu & Kashmir, India
[2] Wollega Univ, Inst Hlth Sci, Dept Pharm, Nekemte, Ethiopia
[3] Mettu Univ, Coll Hlth Sci, Dept Pharm, Mettu, Ethiopia
[4] Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia
[5] Bule Hora Univ, Coll Med & Hlth Sci, Dept Pharm, Bule Hora, Ethiopia
关键词
Substance Use; Nicotine; Opioids; Cigarette Smoking; Psychiatry; Abuse; MENTAL-DISORDERS; SCHIZOPHRENIA; TRENDS;
D O I
10.5812/ans.106492
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Substance-use related disorders (SUD) are a major public health concern worldwide, especially in developing nations. Currently, it is characterized by high rates of mortality and morbidity. Moreover, through increased utilization of healthcare services, it causes both direct and indirect significant medical expenditures. Objectives: The current study aimed to evaluate the pattern of Substance abuse in the department of psychiatry of a Tertiary Care Hospital, Srinagar, Jammu, and Kashmir, India. Methods: This is a descriptive, cross-sectional, and open study conducted in the psychiatry inpatient department of a tertiary care hospital, Srinagar, Jammu, and Kashmir, India, for? months (January to May 2020). Results: Over a period of seven months, a total of 135 participants were recruited (105 males and 30 females). Most of them were Muslim (96.29%), married (68.14%), and living as a nuclear family (75.55%). Tobacco (Nicotine) was the most commonlyused substance by those admitted to the psychiatry ward (62.96%), followed by cannabis (11.11%) and opioids (11.11%). The most comorbidity associated with substance abuse was psychiatric disorders (36.84%), followed by neurological disorders (21.05%), and gastrointestinal disorders (7.89%). Among those with psychiatric disorders,14 (10.37%) had mood (bipolar) disorders. A total of 1129 medicines were prescribed for 135 patients. The mean +/- standard error of the mean (SEM) of the prescribed medicines was 8.48 +/- 3.3. The average number of drugs per encounter was 8.48%. Conclusions: In this study, cigarette smoking (nicotine) was the most commonly abused substance. It can be justified by the fact that Kashmir is a conflict zone, and many people suffer from the post-traumatic stress disorder. Hence, a collaborated effort is necessary to improve the prescribing pattern and to enhance the rational use of medications for better treatment outcomes.
引用
收藏
页数:5
相关论文
共 21 条
  • [1] Global research mapping of substance use disorder and treatment 1971-2017: implications for priority setting
    Bach Xuan Tran
    Moir, Mackenzie
    Latkin, Carl A.
    Hall, Brian J.
    Cuong Tat Nguyen
    Ha, Giang Hai
    Nam Ba Nguyen
    Ho, Cyrus S. H.
    Ho, Roger C. M.
    [J]. SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2019, 14 (1)
  • [2] Socio demographic profile and utilization pattern of antipsychotic drugs among schizophrenic inpatients: a cross sectional study from western region of Nepal
    Banerjee, Indrajit
    Roy, Bedanta
    Sathian, Brijesh
    Banerjee, Indraneel
    Chakraborty, Prasanta Kumar
    Saha, Archana
    [J]. BMC PSYCHIATRY, 2013, 13
  • [3] Psychotropic Medication Use in Canada
    Beck, Cynthia A.
    Williams, Jeanne V. A.
    Wang, Jian Li
    Kassam, Aliya
    El-Guebaly, Nady
    Currie, Shawn R.
    Maxwell, Colleen J.
    Patten, Scott B.
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2005, 50 (10): : 605 - 613
  • [4] Beiranvand V, 2012, 2012 7TH INTERNATIONAL CONFERENCE ON COMPUTING AND CONVERGENCE TECHNOLOGY (ICCCT2012), P332
  • [5] Trends in service use and treatment for mental disorders in adults throughout Great Britain
    Brugha, TS
    Bebbington, PE
    Singleton, N
    Melzer, D
    Jenkins, R
    Lewis, G
    Farrell, M
    Bhugra, D
    Lee, A
    Meltzer, H
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2004, 185 : 378 - 384
  • [6] Gaud RS, 1989, IND J HOS PHARM, V26, P70
  • [7] HOGERZEIL HV, 1995, BRIT J CLIN PHARMACO, V39, P1
  • [8] Khan MA, 2019, MATER RES FOUND, V50, P1, DOI 10.21741/9781644900239-1
  • [9] Koen L, 2008, Afr J Psychiatry (Johannesbg), V11, P287
  • [10] Laporte J R, 1985, Dev Dialogue, P48